Luis Quintas

Dr. Luis Quintas

Federal University of Rio de Janeiro (UFRJ)
orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2008 in Journal of Cell Biology
Verified
Journal Article
Open access
TCTing Cai
Ting Cai
HWHaojie Wang
Haojie Wang
Yiliang ChenYiliang Chen
Yiliang Chen
LLLijun Liu
Lijun Liu
WGWilliam T Gunning
William T Gunning
ZXZi-Jian Xie
Zi-Jian Xie
Here, we show that the Na/K-ATPase interacts with caveolin-1 (Cav1) and regulates Cav1 trafficking. Graded knockdown of Na/K-ATPase decreases the plasma membrane pool of Cav1, which results in a significant reduction in the number of caveolae on the cell surface. These effects are independent of the pumping function of Na/K-ATPase, and instead depend on interaction between Na/K-ATPase and Cav1 mediated by an N-terminal caveolin-binding motif within the ATPase α1 subunit. Moreover, knockdown of the Na/K-ATPase increases basal levels of active Src and stimulates endocytosis of Cav1 from the plasma membrane. Microtubule-dependent long-range directional trafficking in Na/K-ATPase–depleted cells results in perinuclear accumulation of Cav1-positive vesicles. Finally, Na/K-ATPase knockdown has no effect on processing or exit of Cav1 from the Golgi. Thus, the Na/K-ATPase regulates Cav1 endocytic trafficking and stabilizes the Cav1 plasma membrane pool.

2 June 2016 in Frontiers in Physiology
Verified
Journal Article
Open access
PKPaula Fernanda Kinoshita
Paula Fernanda Kinoshita
JLJacqueline Leite
Jacqueline Leite
AOAna Maria Orellana
Ana Maria Orellana
Andrea Rodrigues VasconcelosAndrea Rodrigues Vasconcelos
Andrea Rodrigues Vasconcelos
Luis QuintasLuis Quintas
Luis Quintas
Cristoforo ScavoneCristoforo Scavone
Cristoforo Scavone
Decreased Na+,K+-ATPase (NKA) activity causes energy deficiency, which is commonly observed in neurodegenerative diseases. The NKA is constituted of three subunits: α, β and γ, with four distinct isoforms of the catalytic α subunit (α1-4). Genetic mutations in the ATP1A2 gene and ATP1A3 gene, encoding the α2 and α3 subunit isoforms, respectively can cause distinct neurological disorders, concurrent to impaired NKA activity. Within the central nervous system (CNS), the α2 isoform is expressed mostly in glial cells and the α3 isoform is neuron-specific. Mutations in ATP1A2 gene can result in familial hemiplegic migraine (FHM2), while mutations in the ATP1A3 gene can cause Rapid-onset dystonia-Parkinsonism (RDP) and alternating hemiplegia of childhood (AHC), as well as the cerebellar ataxia, areflexia, pescavus, optic atrophy and sensorineural hearing loss (CAPOS) syndrome. Data indicates that the central glutamatergic system is affected by mutations in the α2 isoform, however further investigations are required to establish a connection to mutations in the α3 isoform, especially given the diagnostic confusion and overlap with glutamate transporter disease. The age-related decline in brain α2/3 activity may arise from changes in the cyclic guanosine monophosphate (cGMP) and cGMP‐dependent protein kinase (PKG) pathway. Glutamate, through nitric oxide synthase (NOS), cGMP and PKG, stimulates brain α2/3 activity, with the glutamatergic N-methyl-D-aspartate (NMDA) receptor cascade able to drive an adaptive, neuroprotective response to inflammatory and challenging stimuli, including amyloid‐β. Here we review the NKA, both as an ion pump as well as a receptor that interacts with NMDA, including the role of NKA subunits mutations. Failure of the NKA-associated adaptive response mechanisms may render neurons more susceptible to degeneration over the course of aging.

1 February 2016 in Toxicon
Verified
Journal Article
Closed access
Wilmer PereraWilmer Perera
Wilmer Perera
SLSuzana Guimarães Leitão
Suzana Guimarães Leitão
GCGeraldino Cunha-Filho
Geraldino Cunha-Filho
RBRoberto Alonso Bosch
Roberto Alonso Bosch
IAIsel Pascual Alonso
Isel Pascual Alonso
FNFrançois Noël
François Noël

1 September 2010 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
Luis QuintasLuis Quintas
Luis Quintas
SPSandrine V. Pierre
Sandrine V. Pierre
LLLijun Liu
Lijun Liu
YBYan Bai
Yan Bai
XLXiaochen Liu
Xiaochen Liu
ZXZi-Jian Xie
Zi-Jian Xie

7 October 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SRSayonarah C. Rocha
Sayonarah C. Rocha
MPMarco T. C. Pessoa
Marco T. C. Pessoa
LNLuiza D. R. Neves
Luiza D. R. Neves
SASilmara L. G. Alves
Silmara L. G. Alves
LSLuciana M. Silva
Luciana M. Silva
LBLeandro Barbosa
Leandro Barbosa
Cardiotonic steroids are used to treat heart failure and arrhythmia and have promising anticancer effects. The prototypic cardiotonic steroid ouabain may also be a hormone that modulates epithelial cell adhesion. Cardiotonic steroids consist of a steroid nucleus and a lactone ring, and their biological effects depend on the binding to their receptor, Na,K-ATPase, through which, they inhibit Na+ and K+ ion transport and activate of several intracellular signaling pathways. In this study, we added a styrene group to the lactone ring of the cardiotonic steroid digoxin, to obtain 21-benzylidene digoxin (21-BD), and investigated the effects of this synthetic cardiotonic steroid in different cell models. Molecular modeling indicates that 21-BD binds to its target Na,K-ATPase with low affinity, adopting a different pharmacophoric conformation when bound to its receptor than digoxin. Accordingly, 21-DB, at relatively high µM amounts inhibits the activity of Na,K-ATPase α1, but not α2 and α3 isoforms. In addition, 21-BD targets other proteins outside the Na,K-ATPase, inhibiting the multidrug exporter Pdr5p. When used on whole cells at low µM concentrations, 21-BD produces several effects, including: 1) up-regulation of Na,K-ATPase expression and activity in HeLa and RKO cancer cells, which is not found for digoxin, 2) cell specific changes in cell viability, reducing it in HeLa and RKO cancer cells, but increasing it in normal epithelial MDCK cells, which is different from the response to digoxin, and 3) changes in cell-cell interaction, altering the molecular composition of tight junctions and elevating transepithelial electrical resistance of MDCK monolayers, an effect previously found for ouabain. These results indicate that modification of the lactone ring of digoxin provides new properties to the compound, and shows that the structural change introduced could be used for the design of cardiotonic steroid with novel functions.

1 February 2002 in Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology
Verified
Journal Article
Closed access
LLLuciane B Lopez
Luciane B Lopez
Luis QuintasLuis Quintas
Luis Quintas
FNFrançois Noël
François Noël